These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 21356072)
21. Intention to treat versus modified intention-to-treat analysis in B-cell maturation antigen and CD19 chimeric antigen receptor trials: A systematic review and meta-analysis. Mohyuddin GR; Atieh T; Ahmed N; Sborov D; McClune B; Abdallah AO; Goodman AM; Aziz M; Allen I; Prasad V Eur J Cancer; 2021 Oct; 156():164-174. PubMed ID: 34454318 [TBL] [Abstract][Full Text] [Related]
22. Quality of reporting for randomized controlled trials in the hypospadias literature: Where do we stand? Braga LH; McGrath M; Easterbrook B; Jegatheeswaran K; Mauro L; Lorenzo AJ J Pediatr Urol; 2017 Oct; 13(5):482.e1-482.e9. PubMed ID: 28566206 [TBL] [Abstract][Full Text] [Related]
23. Methodological reporting of randomized controlled trials in major hepato-gastroenterology journals in 2008 and 1998: a comparative study. Wang JL; Sun TT; Lin YW; Lu R; Fang JY BMC Med Res Methodol; 2011 Jul; 11():110. PubMed ID: 21801429 [TBL] [Abstract][Full Text] [Related]
24. Intention to treat (ITT) analysis as reported in orthodontic randomized controlled trials-evaluations of methodology and recommendations for the accurate use of ITT analysis and handling dropouts. Bondemark L; Abdulraheem S Eur J Orthod; 2018 Jul; 40(4):409-413. PubMed ID: 29069355 [TBL] [Abstract][Full Text] [Related]
25. The association of funding source on effect size in randomized controlled trials: 2013-2015 - a cross-sectional survey and meta-analysis. Falk Delgado A; Falk Delgado A Trials; 2017 Mar; 18(1):125. PubMed ID: 28292317 [TBL] [Abstract][Full Text] [Related]
26. Quality of randomized controlled trials reporting in the treatment of melasma conducted in China. Chen Z; Chen Y; Zeng J; Wang Y; Ye T; Zhou Q; Du X; Su W; Ding Z Trials; 2015 Apr; 16():156. PubMed ID: 25872530 [TBL] [Abstract][Full Text] [Related]
27. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. Bhandari M; Busse JW; Jackowski D; Montori VM; Schünemann H; Sprague S; Mears D; Schemitsch EH; Heels-Ansdell D; Devereaux PJ CMAJ; 2004 Feb; 170(4):477-80. PubMed ID: 14970094 [TBL] [Abstract][Full Text] [Related]
28. The quality of reporting of trial abstracts is suboptimal: survey of major general medical journals. Berwanger O; Ribeiro RA; Finkelsztejn A; Watanabe M; Suzumura EA; Duncan BB; Devereaux PJ; Cook D J Clin Epidemiol; 2009 Apr; 62(4):387-92. PubMed ID: 19010643 [TBL] [Abstract][Full Text] [Related]
29. The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement. Mills EJ; Wu P; Gagnier J; Devereaux PJ Contemp Clin Trials; 2005 Aug; 26(4):480-7. PubMed ID: 16054580 [TBL] [Abstract][Full Text] [Related]
30. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079 [TBL] [Abstract][Full Text] [Related]
31. Conflicts of interest at medical journals: the influence of industry-supported randomised trials on journal impact factors and revenue - cohort study. Lundh A; Barbateskovic M; Hróbjartsson A; Gøtzsche PC PLoS Med; 2010 Oct; 7(10):e1000354. PubMed ID: 21048986 [TBL] [Abstract][Full Text] [Related]
32. The use of the intention-to-treat principle in nursing clinical trials. Polit DF; Gillespie BM Nurs Res; 2009; 58(6):391-9. PubMed ID: 19918150 [TBL] [Abstract][Full Text] [Related]
33. Intention-to-treat analyses in behavioral medicine randomized clinical trials. Pagoto SL; Kozak AT; John P; Bodenlos JS; Hedeker D; Spring B; Schneider KL Int J Behav Med; 2009; 16(4):316-22. PubMed ID: 19319693 [TBL] [Abstract][Full Text] [Related]
34. Methodological reporting quality of randomized controlled trials: A survey of seven core journals of orthopaedics from Mainland China over 5 years following the CONSORT statement. Zhang J; Chen X; Zhu Q; Cui J; Cao L; Su J Orthop Traumatol Surg Res; 2016 Nov; 102(7):933-938. PubMed ID: 27514437 [TBL] [Abstract][Full Text] [Related]
35. A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design. Goswami ND; Tsalik EL; Naggie S; Miller WC; Horton JR; Pfeiffer CD; Hicks CB Trials; 2014 Jan; 15():31. PubMed ID: 24450313 [TBL] [Abstract][Full Text] [Related]
36. The influence of industry sponsorship on the reporting of subgroup analyses within phase III randomised controlled trials in gastrointestinal oncology. Barton S; Peckitt C; Sclafani F; Cunningham D; Chau I Eur J Cancer; 2015 Dec; 51(18):2732-9. PubMed ID: 26608121 [TBL] [Abstract][Full Text] [Related]
37. Selective outcome reporting and sponsorship in randomized controlled trials in IVF and ICSI. Braakhekke M; Scholten I; Mol F; Limpens J; Mol BW; van der Veen F Hum Reprod; 2017 Oct; 32(10):2117-2122. PubMed ID: 28938740 [TBL] [Abstract][Full Text] [Related]
38. Methodological reporting of randomized trials in five leading Chinese nursing journals. Shi C; Tian J; Ren D; Wei H; Zhang L; Wang Q; Yang K PLoS One; 2014; 9(11):e113002. PubMed ID: 25415382 [TBL] [Abstract][Full Text] [Related]
39. Quality of reporting of key methodological items of randomized controlled trials in clinical ophthalmic journals. Lai TY; Wong VW; Lam RF; Cheng AC; Lam DS; Leung GM Ophthalmic Epidemiol; 2007; 14(6):390-8. PubMed ID: 18161613 [TBL] [Abstract][Full Text] [Related]
40. Journal impact factor and methodological quality of surgical randomized controlled trials: an empirical study. Ahmed Ali U; Reiber BMM; Ten Hove JR; van der Sluis PC; Gooszen HG; Boermeester MA; Besselink MG Langenbecks Arch Surg; 2017 Nov; 402(7):1015-1022. PubMed ID: 28578503 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]